Stock BAYN BAYER AG
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra
Other stock markets
 11:39:21 2024-12-12 am EST 		5-day change 1st Jan Change
20.18 EUR +0.90% Intraday chart for Bayer AG +4.75% -40.01%
Dec. 12 Farmers make less profit - calls for a change of course DP
Dec. 12 Significant drop in farmers' profits DP

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Farmers make less profit - calls for a change of course
Dec. 12
 DP
Significant drop in farmers' profits
Dec. 12
 DP
Moberg Pharma, Bayer to Call Off Licensing Deal for Nail Fungus Treatment
Dec. 10
 MT
Bayer continues to recover - Glyphosate mistrial in the USA
Dec. 09
 DP
Bayer: new €5 billion credit line
Dec. 06
 CF
Bayer Secures New EUR5 Billion Revolving Credit Facility
Dec. 06
 MT
Bayer competitor Corteva wants to significantly expand its soybean business in Brazil
Dec. 05
 DP
Bayer: to present its radiology products at RSNA
Dec. 02
 CF
Bayer: expanding its global network of incubators
Nov. 29
 CF
Dhanuka Agritech Limited Announces Strategic Acquisition Agreement with Bayer AG for Acquiring International Rights to the Active Ingredients Iprovalicarb and Triadimenol
Nov. 25
 CI
Dhanuka Agritech Limited Announces Strategic Acquisition Agreement with Bayer AG for Acquiring International Rights to the Active Ingredients Iprovalicarb and Triadimenol to Expand its Global Footprint
Nov. 25
 CI
Dhanuka Agritech to Acquire Crop Protection Active Ingredients from Germany's Bayer
Nov. 25
 MT
Dhanuka Agritech Limited signed an agreement to acquire international rights to the active ingredients Iprovalicarb and Triadimenol from Bayer Aktiengesellschaft.
Nov. 24
 CI
Hua Medicine Terminates Commercialization Agreement with Bayer for Type 2 Diabetes Treatment
Nov. 21
 MT
US FDA Accepts Bayer's Supplemental Application for Prostate Cancer Drug
Nov. 21
 MT
Bayer: new Nubeqa application filed in the USA
Nov. 21
 CF
Bayer at its lowest level in more than 20 years - investors run away
Nov. 21
 DP
Jefferies lowers target for Bayer to 22 euros - 'Hold'
Nov. 20
 DP
Berenberg Cuts Bayer's Price Target Amid 'Minimal' Earnings Growth, Legal Troubles
Nov. 20
 MT
Cytokinetics, Bayer in Japan Licensing Pact for Aficamten
Nov. 19
 DJ
BAYER : Berenberg lowers its target price
Nov. 19
 CF
Bayer secures rights to heart drug in multi-million deal
Nov. 19
 RE
Cytokinetics, Bayer Partner to Develop, Commercialize Potential Cardiomyopathy Treatment in Japan
Nov. 19
 MT
Bayer, Orbia Unit Develop a New Digital Farming Platform
Nov. 19
 MT
Bayer: exclusive licensing agreement with Cytokinetics in Japan
Nov. 19
 CF
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAYN Stock
  4. News Bayer AG
  5. Highlights